Actavis Italy S.p.A.
PolandAll drugs from this manufacturer
-
CYTOSAR is an anticancer medicine used in the treatment of acute myeloid leukemia in adults and children, acute lymphoblastic leukemia, and chronic myeloid leukemia. It may be administered alone or in combination with other anticancer medicines.
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage cytarabine 500 mg ATC: L01BC01
-
The medicinal product is used to treat certain blood cancers, such as acute myeloid leukemia and acute lymphoblastic leukemia, in both adults and children.
Dosage form: powder for preparation of injection solution
Active substance Dosage idarubicin hydrochloride 5 mg ATC: L01DB06
-
The medicine is used to treat certain blood cancers, such as acute myeloid leukemia and acute lymphoblastic leukemia, in both adults and children.
Dosage form: powder for preparation of injection solution
Active substance Dosage idarubicin hydrochloride 10 mg ATC: L01DB06